Key risk factors, collectively referred to as metabolic syndrome, include dyslipidemia, leptin and adiponectin dysregulation, insulin resistance, impaired insulin secretion, and glucose intolerance [2]. Here, ADIPOQ is linked to metabolic syndrome.